ISRCTN96705420已完成未知
The CREAM Study:? ChildRen with Eczema, Antibiotic Management Study: a randomised controlled trial
Cardiff University (UK)0 个研究点目标入组 510 人开始时间: 2012年6月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 510
研究概览
简要总结
2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/26938214
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Children (aged 3 months to less than five years) with atopic eczema (as defined by UK working party criteria) who are presenting in primary care and their treating clinician suspects infected eczema because of at least one of the following:
- •The UK working party criteria state that in order to qualify as a case of atopic eczema with the UK diagnostic criteria, the child MUST have:
- •1. An itch skin condition in the last 12 months
- •2. And three or more of the following:
- •2.1. Onset below age 2 (Not used in children under 4 years old)
- •2.2.History of flexural involvement.
- •2.3. History of general dry skin atopic disease (In children aged under 4 years old, history of atopic disease in a first degree relative may be included)
- •2.4. Personal history of other atopic disease
- •3. The eczema is failing to respond to standard treatment
- •4. There is a flare in the severity or extent of the eczema
- •5. There is weeping, crusting, or pustules
排除标准
- •1. Use of oral or topical antibiotics in the past week
- •2. Use of potent (Betamethasone valerate 0.1%, Betacap, Betesil, Bettamousse, Betnovate, Cutivate, Diprosone, Elocon, Hydrocortisone butyrate, Locoid, Locoid Crelo, Metosyn, Nerisone, Synalar, Aureocort, Betnovate-C, Betnovate-N, Fucibet, Lotriderm, Synalar C, Synalar N, Diprosalic) or very potent (Clarelux, Dermovate, Etrivex, Nerisone Forte, Dermovate-NN) corticosteroids within the past week
- •3. Immune suppression
- •4. Features suggestive of eczema herpeticum (significant pain, punched out lesions)
- •5. Severe infection (systemic upset, cellulitis) ) and/or suspected infection warrants immediate hospitalisation or urgent dermatology referral
- •6. Severity of eczema
- •7. Known renal and / or hepatic impairment
- •8. Allergy to penicillin and erythromycin or allergy to penicillin and contraindication to erythromycin, such as current use of medication that is known to interact with erythromycin
- •9. Allergy the fusidic acid
- •10. Current use of any medication that is known to interact with fuscidic acid
- •11. Extensive eczema (EASI score ? 40 [equates to moderately severe eczema affecting 80% of body surface area])
研究者
相似试验
进行中(未招募)
1 期
The CREAM Study - Children with Eczema Antibiotic Management StudyEUCTR2011-003591-37-GBCardiff University113
进行中(未招募)
不适用
A Pilot Study of Efficacy and Safety of SIM05 in Adults with Atopic EczemaAtopic EczemaNCT06230991Chinese University of Hong Kong30
已完成
4 期
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic DermatitisAtopic DermatitisNCT00828412Promius Pharma, LLC100
已完成
2 期
The PEBBLES study: Prevention of Eczema By a Barrier Lipid Equilibrium StrategyeczemaSkin - Dermatological conditionsACTRN12613000472774Murdoch Childrens Research Institute80
已完成
不适用
GB-EZ-SIM03 Probiotics Study for Childhood EczemaEczemaNCT05607511Chinese University of Hong Kong20
